Werewolf Therapeutics (HOWL) Interest Coverage Ratio (2023 - 2026)
Werewolf Therapeutics' (HOWL) quarterly Interest Coverage Ratio came in at 15.07 in Q2 2026, up 211.76% year-over-year from 4.83 in Q2 2025, and up 255.34% quarter-over-quarter from 9.7 in Q1 2026.
Analysis
Werewolf Therapeutics (HOWL) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Werewolf Therapeutics (HOWL) has reported Interest Coverage Ratio for 4 consecutive years, with 15.07 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest Coverage Ratio rose 211.76% year-over-year to 15.07 in Q2 2026; TTM through Jun 2026 was 6.87, a 52.28% increase from a year earlier, with the FY2025 full-year figure at 11.5, up 27.21% from the prior year.
- Interest Coverage Ratio was 15.07 for Q2 2026 at Werewolf Therapeutics, up from 9.7 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 15.07 in Q2 2026 and troughed at 71.06 in Q1 2023.
- A 4-year average of 14.57 and a median of 13.16 in 2025 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio slumped 161.34% in 2024 and surged 211.76% in 2026, its largest moves.
- Over 4 years, Interest Coverage Ratio stood at 12.83 in 2023, then declined by 25.14% to 16.06 in 2024, then soared by 57.16% to 6.88 in 2025, then soared by 319.05% to 15.07 in 2026.
- The last three Interest Coverage Ratio figures came in at 15.07 (Q2 2026), 9.7 (Q1 2026), and 6.88 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.58 Bn | 192.59 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 180.17 Bn | 176.99 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 130.59 Bn | 122.74 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.61 Bn | 73.61 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.24 Bn | 55.05 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.29 Bn | 49.15 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 32.96 Bn | 29.65 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.94 Bn | 30.66 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.38 Bn | 29.38 Bn | 1.16 Mn | - |
| 10 | Werewolf Therapeutics | 46.85 Mn | 46.85 Mn | - | 15.07 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.07 |
| Mar 31, 2026 | -9.70 |
| Dec 31, 2025 | -6.88 |
| Sep 30, 2025 | -11.73 |
| Jun 30, 2025 | -13.48 |
| Mar 31, 2025 | -14.24 |
| Dec 31, 2024 | -16.06 |
| Sep 30, 2024 | -13.77 |
| Jun 30, 2024 | -16.60 |
| Mar 31, 2024 | -17.11 |
| Dec 31, 2023 | -12.83 |
| Sep 30, 2023 | -9.23 |
| Jun 30, 2023 | -6.35 |
| Mar 31, 2023 | -71.06 |